Cancer

Study IDs Two New Breast Cancer Genes in Black Women

A groundbreaking genetic study identified two novel breast cancer-linked genetic variants in Black South African women.

Cancer

ctMoniTR Project Gets new Research Findings from Biodesix and Bio-Rad

Biodesix and Bio-Rad contributed findings to ctMoniTR showing that changes in ctDNA are strongly associated with treatment outcomes.

Cancer

AI Model Enhances Prognostic Accuracy with Multi-Omics Integration

MULGONET, a novel multi-omics framework, improves tumor recurrence prediction by integrating gene ontology-guided architecture.

Avantect Pancreatic Cancer Test Now Available

Mar 13, 2025 | Pancreatic

ClearNote Health has partnered with Claritev to make its Avantect Pancreatic Cancer Test available in Claritev’s PHCS and MultiPlan Networks.

Rethinking Breast Cancer Screening

Mar 12, 2025 | Breast

A new editorial discusses findings from the COMET trial, suggesting that early-stage breast cancer may not require immediate surgery.

Race-Associated Differences in Pancreatic Cancer Discovered

Mar 12, 2025 | Pancreatic

Researchers have identified race-associated differences in pancreatic cancer, highlighting the need for diverse clinical trial participation.

Neuroblastoma Diagnostics Driven by Artificial Intelligence

Mar 11, 2025 | Unknown Origin & Other Cancer Types

A study on neuroblastoma with bone or bone marrow metastasis (NB-BBM) used deep learning to uncover biomarkers.

tsRNAs Are Potential Digestive Tract Disease Biomarkers

Mar 10, 2025 | Cancer

A new study highlights the role of tsRNAs as potential biomarkers and therapeutic targets for digestive tract diseases.

ExRNA Plays a Role in Head and Neck Cancers

Mar 6, 2025 | Unknown Origin & Other Cancer Types

A study highlights the role of exRNA in head and neck cancers (HNCs), emphasizing their potential as non-invasive biomarkers for diagnosis.

Genomic Profiling Solution Only Requires Simple Blood Draw

Feb 27, 2025 | Cancer

Labcorp Plasma Complete is a ctDNA-based liquid biopsy test, enabling comprehensive genomic profiling from a simple blood draw.

Study Further Validates Prognostic Test for Barrett’s Esophagus

Feb 24, 2025 | Unknown Origin & Other Cancer Types

A study validates Esopredict, a DNA methylation-based test, in assessing Barrett’s esophagus patients’ risk of neoplastic progression.

Pancreatic Cancer Test Wins Approval from NYS Department of Health

Feb 18, 2025 | Pancreatic

ClearNote Health has received approval from the New York State Department of Health for its Avantect Pancreatic Cancer Test.

Lung Cancer Detection May Have Gotten Easier

Feb 6, 2025 | Lung Cancer

Scientists have developed a low-cost, fast-response sensor capable of detecting lung cancer biomarkers from a blood sample in just 40 minutes.

HER2-ultralow Metastatic Breast Cancer Companion Diagnostic Approved by FDA

Feb 4, 2025 | Breast

Roche’s PATHWAY anti-HER2/neu (4B5) test has received FDA approval to ID patients with HR-positive, HER2-ultralow metastatic breast cancer.

Lynx Dx Launches At-Home Prostate Cancer Test

Feb 3, 2025 | Prostate

Lynx Dx announced at-home availability of a urine-based prostate cancer test that eliminates the need for a digital rectal exam.

Why Self-collection Is the Means to Maximize Cervical Cancer Screening

Jan 31, 2025 | Cervical (HPV)

There are significant barriers to cervical cancer screening. Sample self-collection promises to improve access to testing and treatment.

Urine Test Detects Prostate Cancer and Reduces Unnecessary Biopsies

Jan 29, 2025 | Prostate, Urinalysis & Toxicology

A new study validated a urine test that offers a less invasive, more accurate alternative to traditional prostate cancer screening.

Novel Lab-on-Chip Platform Aims to Expedite Cancer Diagnoses

Jan 28, 2025 | Cancer

A new lab-on-chip platform uses standing surface acoustic waves and AI to separate CTCs from red blood cells for earlier cancer diagnosis.

Category: Cancer

Cancer

Cancer

Cancer